IL33 and nasal cavity polyp: We aimed to study tissue IL-33 in CRSwNP, using an enzyme-linked immunosorbent assay (ELISA) to investigate its involvement as a novel potential regulator of innate immunity, and biomarker of disease severity, in chronic rhinosinusitis with nasal polyps.